Helen E. Kent
- Co-authors
- Stephen J. KentJennifer A. JunoMiles P. DavenportWen Shi LeeArnold ReynaldiAdam K. WheatleyHyon‐Xhi TanKathleen M. Wragg
- Topics
- SARS-CoV-2 and COVID-19 Research (7 papers)COVID-19 Clinical Research Studies (4 papers)vaccines and immunoinformatics approaches (1 paper)
- Journals
- Nature MedicineACS NanoImmunity
In The Last Decade
Helen E. Kent
12 papers receiving 379 citations
Peers
Comparison fields: 5 of 58
- Infectious Diseases 291
- Immunology 104
- Molecular Biology 74
- Neurology 70
- Epidemiology 31
Countries citing papers authored by Helen E. Kent
This map shows the geographic impact of Helen E. Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Kent more than expected).
Fields of papers citing papers by Helen E. Kent
This network shows the impact of papers produced by Helen E. Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Kent. The network helps show where Helen E. Kent may publish in the future.
Co-authorship network of co-authors of Helen E. Kent
This figure shows the co-authorship network connecting the top 25 collaborators of Helen E. Kent. A scholar is included among the top collaborators of Helen E. Kent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen E. Kent. Helen E. Kent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 10 | |
| 3 | 1 | |
| 4 | 28 | |
| 5 | 23 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 11 | |
| 9 | 9 | |
| 10 | 260 | |
| 11 | 8 | |
| 12 | 3 |
About Helen E. Kent
Helen E. Kent is a scholar working on Virology, Infectious Diseases and Modeling and Simulation, having authored 12 papers that have together received 386 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (4 papers) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Infectious Diseases (291 citations), Modeling and Simulation (28 citations) and Immunology (104 citations). Helen E. Kent has collaborated with scholars based in Australia, Singapore and Canada. Frequent co-authors include Stephen J. Kent, Jennifer A. Juno, Miles P. Davenport, Wen Shi Lee, Arnold Reynaldi, Adam K. Wheatley, Hyon‐Xhi Tan, Kathleen M. Wragg, Robyn Esterbauer and Melanie H. Dietrich. Their work appears in journals such as Nature Medicine, ACS Nano and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.